Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP376053.RAc14J2yL_6xb0LqMlagyF1yj3If7egfF6SvJu9LRi-yc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP376053.RAc14J2yL_6xb0LqMlagyF1yj3If7egfF6SvJu9LRi-yc130_assertion type Assertion NP376053.RAc14J2yL_6xb0LqMlagyF1yj3If7egfF6SvJu9LRi-yc130_head.
- NP376053.RAc14J2yL_6xb0LqMlagyF1yj3If7egfF6SvJu9LRi-yc130_assertion description "[In clinical samples, EphA5 methylation was detected in 64.1% (75/117) of breast tumors and 28.2% (33/117) of paired normal tissues (P < .001), which was associated with higher tumor grade (P = .024), lymph node metastasis (P = .004), and progesterone receptor-negative status (P = .008).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376053.RAc14J2yL_6xb0LqMlagyF1yj3If7egfF6SvJu9LRi-yc130_provenance.
- NP376053.RAc14J2yL_6xb0LqMlagyF1yj3If7egfF6SvJu9LRi-yc130_assertion evidence source_evidence_literature NP376053.RAc14J2yL_6xb0LqMlagyF1yj3If7egfF6SvJu9LRi-yc130_provenance.
- NP376053.RAc14J2yL_6xb0LqMlagyF1yj3If7egfF6SvJu9LRi-yc130_assertion SIO_000772 19733895 NP376053.RAc14J2yL_6xb0LqMlagyF1yj3If7egfF6SvJu9LRi-yc130_provenance.
- NP376053.RAc14J2yL_6xb0LqMlagyF1yj3If7egfF6SvJu9LRi-yc130_assertion wasDerivedFrom befree-20150227 NP376053.RAc14J2yL_6xb0LqMlagyF1yj3If7egfF6SvJu9LRi-yc130_provenance.
- NP376053.RAc14J2yL_6xb0LqMlagyF1yj3If7egfF6SvJu9LRi-yc130_assertion wasGeneratedBy ECO_0000203 NP376053.RAc14J2yL_6xb0LqMlagyF1yj3If7egfF6SvJu9LRi-yc130_provenance.